drugset / Trial / NCT00196365

A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain

NCT00196365

Phase 3 Completed 97 enrolled Duramed Research
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is being conducted to evaluate the effects of treatment with Seasonique an extended-regimen oral contraceptive that utilizes low dose ethinyl estradiol during the typical hormone-free interval. Patients will receive 26 weeks of treatment. The overall study duration will be approximately 9 months. Patients will be required to record menstrual pain in a daily diary.

Timeline

Start
2005-01
Primary completion
2007-07
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject ethinyl estradiol Small molecule 0.03 mg Oral
Background Levonorgestrel Small molecule 0.15 mg Oral

Indications